MBA from Babson College; MS in Chemistry from the City University of New York; BS in Pharmaceutical Sciences from West China Medical Center, Sichuan University

Over 20 years of experience in pharmaceutical R&D, manufacturing, management and investment.

Chairman, Sunforest Capital

Managing Partner, Yuanming Capital

Partner, Mingxin China Growth Fund

China General Manager, Chiral Quest

Senior Scientist, Eisai Research Institute

Scientist, Wyeth

Enzymaster, Pharbers Genesis, Novaxelgen, InnoModels Bio, Readitec, United Imaging, CF PharmTech, Adlai Nortye, Sironax, Pharmacodia, Ascentage Pharma (06855.HK), Ansun, JW Therapeutics (02126.HK), Sonicmed, Yocaly Enterprise, Hengrui (600276), Innovent, Asymchem, Zai Lab (NASDAQ: ZLAB), BeiGene (688235), Porten (300363), SINQI (300573) and Tigermed (300347)